Replies to post #27603 on PharmaCyte Biotech Inc (PMCB)

[Jimmy Joe]

So... Nuvilex is now working on several fronts. Focus is on inoperable pancreatic cancer with a secondary focus on type 1 diabetes.

Now we know why they needed up to $50 million from Chardan Capital.

Lots going on at Nuvilex.

JJ

[$Pistol Pete$]

The announcement of the Nuvilex agreement has coincided with the awarding of a National Health and Medical Research Council (NHMRC) grant to Professor Simpson for related work. Over the past 20 years she has received more than $7 million to advance research aimed at reversing Type 1 diabetes by using the liver as a surrogate system to produce insulin.

$NVLX

Pistol Pete!